NCT05566717 (Assess) is a clinical trial in Diabetic Retinopathy, sponsored by Medical Center Ophthalmology Associates.

Who is sponsoring NCT05566717?

NCT05566717 is sponsored by Medical Center Ophthalmology Associates.

What condition does NCT05566717 study?

NCT05566717 studies Diabetic Retinopathy, Neurotrophic Keratitis.

Is NCT05566717 still recruiting?

NCT05566717 is currently status unknown. Last updated 4 October 2022.

Last reviewed 2022-10-04 · How we verify

NCT05566717: Assess

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

An Investigator-Initiated Study to Assess the Association of Diabetic Retinopathy Severity Scale (DRSS) With Level of Decreased Corneal Sensitivity

Status unknown Last updated 4 October 2022

What this trial tests

trial in Diabetic Retinopathy in 50 participants. Status unknown.

Timeline

1 July 2022

Primary endpoint
30 September 2022

31 October 2022

Quick facts

Lead sponsor	Medical Center Ophthalmology Associates
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50
Start date	1 July 2022
Primary completion	30 September 2022
Estimated completion	31 October 2022
Sites	1 location across United States

Conditions studied

Diabetic Retinopathy — all drugs for Diabetic Retinopathy →
Neurotrophic Keratitis — all drugs for Neurotrophic Keratitis →

Sponsor

Medical Center Ophthalmology Associates

Who can join

18 and older, any sex, with Diabetic Retinopathy or Neurotrophic Keratitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluate the association between level of decreased corneal sensitivity and diabetic retinopathy severity scale

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Diabetic Retinopathy

Currently open trials in the same condition.

NCT07255326 — Effect of Omega-3 Fatty Acids on Eye Blood Vessels in Type 1 Diabetes · NA · recruiting
NCT06782997 — Performance of the Electroretinogram, Performed and Interpreted by an Advanced Practice Nurse, in the Screening for Diab · recruiting
NCT07002372 — Effect of Video Viewing on Intravitreal Injection Experience · NA · recruiting
NCT06713720 — Remote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy · NA · recruiting
NCT06892353 — AI-Powered DIY Screening System for Diabetic Retinopathy · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05566717 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical Center Ophthalmology Associates
Last refreshed: 4 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05566717.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing